Literature DB >> 25211735

The influence of race and comorbidity on the timely initiation of antiretroviral therapy among older persons living with HIV/AIDS.

Winston E Abara1, Lerissa Smith, Shun Zhang, Amanda J Fairchild, Harry J Heiman, George Rust.   

Abstract

OBJECTIVES: We examined whether the timely initiation of antiretroviral therapy (ART) differed by race and comorbidity among older (≥ 50 years) people living with HIV/AIDS (PLWHA).
METHODS: We conducted frequency and descriptive statistics analysis to characterize our sample, which we drew from 2005-2007 Medicaid claims data from 14 states. We employed univariate and multivariable Cox regression analyses to evaluate the relationship between race, comorbidity, and timely ART initiation (≤ 90 days post-HIV/AIDS diagnosis).
RESULTS: Approximately half of the participants did not commence ART promptly. After we adjusted for covariates, we found that older PLWHA who reported a comorbidity were 40% (95% confidence interval = 0.26, 0.61) as likely to commence ART promptly. We found no racial differences in the timely initiation of ART among older PLWHA.
CONCLUSIONS: Comorbidities affect timely ART initiation in older PLWHA. Older PLWHA may benefit from integrating and coordinating HIV care with care for other comorbidities and the development of ART treatment guidelines specific to older PLWHA. Consistent Medicaid coverage helps ensure consistent access to HIV treatment and care and may eliminate racial disparities in timely ART initiation among older PLWHA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25211735      PMCID: PMC4202940          DOI: 10.2105/AJPH.2014.302227

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  56 in total

1.  HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient.

Authors:  W H Adler; P V Baskar; F J Chrest; B Dorsey-Cooper; R A Winchurch; J E Nagel
Journal:  Mech Ageing Dev       Date:  1997-06       Impact factor: 5.432

2.  Racial/ethnic disparities in HIV diagnoses among persons aged 50 years and older in 37 US States, 2005-2008.

Authors:  Laurie Linley; Joseph Prejean; Qian An; Mi Chen; H Irene Hall
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

3.  General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era.

Authors:  A M Kilbourne; A C Justice; L Rabeneck; M Rodriguez-Barradas; S Weissman
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

4.  Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.

Authors:  W E Cunningham; L E Markson; R M Andersen; S H Crystal; J A Fleishman; C Golin; A Gifford; H H Liu; T T Nakazono; S Morton; S A Bozzette; M F Shapiro; N S Wenger
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

5.  Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; Jose M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; Stefano Vella; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

6.  Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

Authors:  Kelly A Gebo; John A Fleishman; Richard Conviser; Erin D Reilly; P Todd Korthuis; Richard D Moore; James Hellinger; Philip Keiser; Haya R Rubin; Lawrence Crane; Fred J Hellinger; W Christopher Mathews
Journal:  J Acquir Immune Defic Syndr       Date:  2005-01-01       Impact factor: 3.731

7.  Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.

Authors:  M M Lederman; R McKinnis; D Kelleher; A Cutrell; J Mellors; M Neisler; E Cooney; D W Haas; R Haubrich; J Stanford; J Horton; A Landay; W Spreen
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

8.  Virologic and immunologic response to HAART, by age and regimen class.

Authors:  Keri N Althoff; Amy C Justice; Stephen J Gange; Steven G Deeks; Michael S Saag; Michael J Silverberg; M John Gill; Bryan Lau; Sonia Napravnik; Ellen Tedaldi; Marina B Klein; Kelly A Gebo
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

9.  "You're awfully old to have this disease": experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS.

Authors:  Charles A Emlet
Journal:  Gerontologist       Date:  2006-12

10.  Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.

Authors:  Muktar H Aliyu; Meridith Blevins; Deidra D Parrish; Karen M Megazzini; Usman I Gebi; Mukhtar Y Muhammad; Mukhtar L Ahmed; Adiba Hassan; Bryan E Shepherd; Sten H Vermund; C William Wester
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

View more
  11 in total

1.  Older African Americans and the HIV Care Continuum: A Systematic Review of the Literature, 2003-2018.

Authors:  Thurka Sangaramoorthy; Amelia Jamison; Typhanye Dyer
Journal:  AIDS Behav       Date:  2019-04

Review 2.  Healthy Aging in Older Women Living with HIV Infection: a Systematic Review of Psychosocial Factors.

Authors:  Anna A Rubtsova; Mirjam-Colette Kempf; Tonya N Taylor; Deborah Konkle-Parker; Gina M Wingood; Marcia McDonnell Holstad
Journal:  Curr HIV/AIDS Rep       Date:  2017-02       Impact factor: 5.071

3.  SENSITIVITY ANALYSIS FOR UNMEASURED CONFOUNDING IN COARSE STRUCTURAL NESTED MEAN MODELS.

Authors:  Shu Yang; Judith J Lok
Journal:  Stat Sin       Date:  2018-10       Impact factor: 1.261

4.  Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.

Authors:  Terra V Fatukasi; Stephen R Cole; Richard D Moore; William C Mathews; Jessie K Edwards; Joseph J Eron
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

5.  Prevalence and Factors Associated With Statin Use Among a Nationally Representative Sample of US Adults: National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Demilade Adedinsewo; Nchang Taka; Pradyumna Agasthi; Rajesh Sachdeva; George Rust; Anekwe Onwuanyi
Journal:  Clin Cardiol       Date:  2016-08-09       Impact factor: 2.882

6.  Correlates of Combination Antiretroviral Adherence Among Recently Diagnosed Older HIV-Infected Adults Between 50 and 64 years.

Authors:  Winston E Abara; Oluwatoyosi A Adekeye; Junjun Xu; Harry J Heiman; George Rust
Journal:  AIDS Behav       Date:  2016-11

7.  A systematic review of engagement in care and health care utilization among older adults living with HIV and non-communicable diseases.

Authors:  Moka Yoo-Jeong; Ashley Anderson; Brittany Ray Gannon; Rebecca Schnall
Journal:  AIDS Care       Date:  2021-07-12

8.  Symptoms and Comorbidities Differ Based on Race and Weight Status in Persons with HIV in the Northern United States: a Cross-Sectional Study.

Authors:  Kierra R Butler; Faye R Harrell; Bridgett Rahim-Williams; Jeffrey M Robinson; Xuemin Zhang; Adwoa Gyamfi; Judith A Erlen; Wendy A Henderson
Journal:  J Racial Ethn Health Disparities       Date:  2022-03-10

9.  HIV Screening Rates among Medicaid Enrollees Diagnosed with Other Sexually Transmitted Infections.

Authors:  Oluwatoyosi A Adekeye; Winston E Abara; Junjun Xu; Joel M Lee; George Rust; David Satcher
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

10.  Identifying social and economic barriers to regular care and treatment for Black men who have sex with men and women (BMSMW) and who are living with HIV: a qualitative study from the Bruthas cohort.

Authors:  Emily A Arnold; John Weeks; Michael Benjamin; William R Stewart; Lance M Pollack; Susan M Kegeles; Don Operario
Journal:  BMC Health Serv Res       Date:  2017-01-28       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.